Coexistence of medullary thyroid carcinoma and recurrent non-functional pituitary adenoma: a case report
- PMID: 30107852
- PMCID: PMC6092822
- DOI: 10.1186/s13256-018-1745-5
Coexistence of medullary thyroid carcinoma and recurrent non-functional pituitary adenoma: a case report
Abstract
Background: Medullary thyroid carcinoma and pituitary adenoma are neuroendocrine tumors and their coexistence has not been reported in the literature, previously. Medullary thyroid carcinoma is a neoplasm of the thyroid gland arising from parafollicular c-cells producing calcitonin, and pituitary adenoma is a benign hyperplasia of the cells of the pituitary gland. Coexistence of these neoplasms can be explained by being affected by simultaneous primary neoplasms or tumor-to-tumor metastasis phenomenon.
Case presentation: We present the case of a 60-year-old Persian man who presented to the clinic with a chief complaint of headache for the last 2 months. His past medical history was significant for non-functional pituitary macroadenoma and medullary thyroid carcinoma and he had received a total thyroidectomy and a transsphenoidal surgery several years ago. Diagnostic evaluations revealed that the pituitary adenoma has recurred. He was well and symptom-free after the second transsphenoidal surgery for resection of the adenoma. Noticeably, investigations were negative for any form of multiple endocrine neoplasia syndromes; however, we could not rule them out definitively.
Conclusions: To the best of our knowledge, it is the first case reported in the literature of a patient who has been affected by recurrent non-functional pituitary adenoma and medullary thyroid carcinoma, concomitantly. Although this association can be accidental, it emphasizes the fact that patients with a history of a neoplasm should be monitored regularly in order to diagnose and treat possible second primary cancers in a timely manner. Of note, this consideration is of great importance in patients whose first neoplasms have better prognosis and survival rates, which provide them more time to develop second primary cancers, for example, pituitary adenoma.
Keywords: Medullary; Multiple endocrine neoplasia; Pituitary adenoma; Pituitary neoplasms; Thyroid cancer; Thyroid neoplasms.
Conflict of interest statement
Ethics approval and consent to participate
Not applicable.
Consent for publication
A written informed consent was obtained from the patient for publication of this case report. A copy of the written consent is available upon request by the Editor-in-Chief of this journal.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Similar articles
-
Coexistence of thyrotropin-producing pituitary adenoma with papillary adenocarcinoma of the thyroid--a case report and surgical strategy.Pituitary. 2001 Sep;4(4):271-4. doi: 10.1023/a:1020758716771. Pituitary. 2001. PMID: 12501979
-
Medullary thyroid carcinoma with double negative calcitonin and CEA: a case report and update of literature review.BMC Endocr Disord. 2019 Oct 16;19(1):103. doi: 10.1186/s12902-019-0435-7. BMC Endocr Disord. 2019. PMID: 31619220 Free PMC article. Review.
-
Pituitary metastasis from medullary carcinoma of thyroid: case report and review of literature.J Neurooncol. 2008 Aug;89(1):63-7. doi: 10.1007/s11060-008-9586-5. Epub 2008 Apr 12. J Neurooncol. 2008. PMID: 18408891 Review.
-
Cytologic diagnosis of recurrent medullary thyroid carcinoma with oncocytic change twenty-one years post-thyroidectomy: case report and review of the literature.Diagn Cytopathol. 2011 Sep;39(9):641-6. doi: 10.1002/dc.21438. Epub 2010 Oct 14. Diagn Cytopathol. 2011. PMID: 20949456 Review.
-
Cytology of hyalinising trabecular adenoma-like variant of medullary thyroid carcinoma.J Cancer Res Ther. 2011 Apr-Jun;7(2):189-91. doi: 10.4103/0973-1482.82916. J Cancer Res Ther. 2011. PMID: 21768710
Cited by
-
RET Regulates Human Medullary Thyroid Cancer Cell Proliferation through CDK5 and STAT3 Activation.Biomolecules. 2021 Jun 9;11(6):860. doi: 10.3390/biom11060860. Biomolecules. 2021. PMID: 34207842 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous